Search

Your search keyword '"Alexey Smolin"' showing total 4 results
Start Over Author "Alexey Smolin" Publisher elsevier bv
4 results on '"Alexey Smolin"'

3. Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

Author

Kazuhiko Nakagawa, F. Liu, Alexey Smolin, Solange Peters, Naiyer A. Rizvi, K.H. Lee, Niels Reinmuth, M. van den Heuvel, S. Le Moulec, M. Cobo Dols, Myung-Ju Ahn, P. Thiyagarajah, Byoung Chul Cho, Gilles Robinet, Scott J. Antonia, Edward B. Garon, Alexander Luft, David Vicente, Ronald B. Natale, and Vladimir Moiseyenko

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, Durvalumab, business.industry, medicine.medical_treatment, First line, Hematology, Chemotherapy regimen, Internal medicine, medicine, In patient, business, Tremelimumab, medicine.drug
Published
2019

4. Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Author

Myung-Ju Ahn, Niels Reinmuth, M. van den Heuvel, Luping Zhao, S. Le Moulec, M. Cobo, Alexey Smolin, Naiyer A. Rizvi, Scott J. Antonia, Vladimir Moiseyenko, Solange Peters, Ronald B. Natale, Alexander Luft, B. Chul Cho, Vikram Chand, Paul K. Stockman, Kazuhiko Nakagawa, Gilles Robinet, David Vicente, and K.H. Lee

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, Chemotherapy, Durvalumab, business.industry, medicine.medical_treatment, Hematology, medicine.disease, Chemotherapy regimen, First line treatment, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Non small cell, business, Lung cancer, Tremelimumab, medicine.drug
Published
2018

Catalog

Books, media, physical & digital resources
See catalog results